Literature DB >> 24941376

NK cells in the tumor microenvironment.

Stine K Larsen1, Yanhua Gao2, Per H Basse3.   

Abstract

The presence of natural killer (NK) cells in the tumor microenvironment correlates with outcome in a variety of cancers. However, the role of intratumoral NK cells is unclear. Preclinical studies have shown that, while NK cells efficiently kill circulating tumor cells of almost any origin, they seem to have very little effect against the same type of tumor cells when these have extravasated. The ability to kill extravasated tumor cells is, however, is dependent of the level of activation of the NK cells, as more recent published and unpublished studies, discussed below, have demonstrated that interleukin-2-activated NK cells are able to attack well-established solid tumors.

Entities:  

Mesh:

Year:  2014        PMID: 24941376      PMCID: PMC4062922          DOI: 10.1615/critrevoncog.2014011142

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  77 in total

1.  [The effect of activated pulmonary natural killer (NK) cells by poly I:C on the established pulmonary metastasis].

Authors:  A Murata
Journal:  Nihon Ika Daigaku Zasshi       Date:  1989-08

2.  Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.

Authors:  G Dennert; C Landon; E M Lord; D W Bahler; J G Frelinger
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

3.  Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.

Authors:  H Takeuchi; Y Maehara; E Tokunaga; T Koga; Y Kakeji; K Sugimachi
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

4.  Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon.

Authors:  K L Fresa; R Korngold; D M Murasko
Journal:  Cell Immunol       Date:  1985-04-01       Impact factor: 4.868

5.  Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells.

Authors:  Lee-Hwa Tai; Christiano Tanese de Souza; Simon Bélanger; Lundi Ly; Almohanad A Alkayyal; Jiqing Zhang; Julia L Rintoul; Abhirami A Ananth; Tiffany Lam; Caroline J Breitbach; Theresa J Falls; David H Kirn; John C Bell; Andrew P Makrigiannis; Rebecca A Auer
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

6.  Alpha-methyl-p-tyrosine reduces poly I:C-induced augmenting interferon production and splenic natural killer cell activity in mice.

Authors:  S J Won; M T Lin
Journal:  Pharmacology       Date:  1993-06       Impact factor: 2.547

7.  Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

Authors:  Marco Wendel; Ioanna E Galani; Elisabeth Suri-Payer; Adelheid Cerwenka
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.

Authors:  M J Brunda; D Rosenbaum; L Stern
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

9.  A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy.

Authors:  B A Pockaj; J C Yang; M T Lotze; J R Lange; W F Spencer; S M Steinberg; S L Topalian; D J Schwartzentruber; D E White; S A Rosenberg
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1994-01

10.  Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma.

Authors:  Jacek Jan Sznurkowski; Anton Zawrocki; Wojciech Biernat
Journal:  Cancer Immunol Immunother       Date:  2013-12-25       Impact factor: 6.968

View more
  52 in total

1.  IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid.

Authors:  D Croxatto; S Martini; L Chiossone; F Scordamaglia; C F Simonassi; L Moretta; M C Mingari; P Vacca
Journal:  Oncoimmunology       Date:  2017-02-17       Impact factor: 8.110

2.  CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.

Authors:  Shi Yong Neo; Ying Yang; Julien Record; Ran Ma; Xinsong Chen; Ziqing Chen; Nicholas P Tobin; Emily Blake; Christina Seitz; Ron Thomas; Arnika Kathleen Wagner; John Andersson; Jana de Boniface; Jonas Bergh; Shannon Murray; Evren Alici; Richard Childs; Martin Johansson; Lisa S Westerberg; Felix Haglund; Johan Hartman; Andreas Lundqvist
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 3.  Complex interplay between tumor microenvironment and cancer therapy.

Authors:  Minhong Shen; Yibin Kang
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

4.  Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells.

Authors:  Hemant K Mishra; Nabendu Pore; Emil F Michelotti; Bruce Walcheck
Journal:  Cancer Immunol Immunother       Date:  2018-07-05       Impact factor: 6.968

5.  Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.

Authors:  Sourav Bhattacharya; Naoshad Muhammad; Robert Steele; Jacki Kornbluth; Ratna B Ray
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-02

6.  Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.

Authors:  Paolo Neviani; Petra M Wise; Mariam Murtadha; Cathy W Liu; Chun-Hua Wu; Ambrose Y Jong; Robert C Seeger; Muller Fabbri
Journal:  Cancer Res       Date:  2018-12-12       Impact factor: 12.701

7.  Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.

Authors:  Franziska Eckert; Ivan Jelas; Moritz Oehme; Stephan M Huber; Katja Sonntag; Christian Welker; Stephen D Gillies; Wolfgang Strittmatter; Daniel Zips; Rupert Handgretinger; Karin Schilbach
Journal:  Oncoimmunology       Date:  2017-04-28       Impact factor: 8.110

8.  Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.

Authors:  Elisabetta Cariani; Massimo Pilli; Valeria Barili; Emanuela Porro; Elisabetta Biasini; Andrea Olivani; Raffaele Dalla Valle; Tommaso Trenti; Carlo Ferrari; Gabriele Missale
Journal:  Oncoimmunology       Date:  2016-03-04       Impact factor: 8.110

Review 9.  Overview of current immunotherapeutic strategies for glioma.

Authors:  Anda-Alexandra Calinescu; Neha Kamran; Gregory Baker; Yohei Mineharu; Pedro Ricardo Lowenstein; Maria Graciela Castro
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

10.  NK cells in the tumor microenvironment and thioredoxin activity.

Authors:  Theresa L Whiteside
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.